SE395221B - Sett att framstella en homogen fast blandning av fasta utgangskomponenter - Google Patents

Sett att framstella en homogen fast blandning av fasta utgangskomponenter

Info

Publication number
SE395221B
SE395221B SE7110354A SE1035471A SE395221B SE 395221 B SE395221 B SE 395221B SE 7110354 A SE7110354 A SE 7110354A SE 1035471 A SE1035471 A SE 1035471A SE 395221 B SE395221 B SE 395221B
Authority
SE
Sweden
Prior art keywords
solid
homogenic
produce
way
basic components
Prior art date
Application number
SE7110354A
Other languages
English (en)
Swedish (sv)
Inventor
Och T J Maxwell A R Briggs
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of SE395221B publication Critical patent/SE395221B/xx

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • F26B5/065—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing the product to be freeze-dried being sprayed, dispersed or pulverised
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/0231—Chemically defined matrices, e.g. alginate gels, for immobilising, holding or storing cells, tissue or organs for preservation purposes; Chemically altering or fixing cells, tissue or organs, e.g. by cross-linking, for preservation purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/98—Preparation of granular or free-flowing enzyme compositions
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
    • F25C—PRODUCING, WORKING OR HANDLING ICE
    • F25C1/00—Producing ice
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Mechanical Engineering (AREA)
  • Thermal Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
SE7110354A 1970-08-14 1971-08-13 Sett att framstella en homogen fast blandning av fasta utgangskomponenter SE395221B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6394270A 1970-08-14 1970-08-14

Publications (1)

Publication Number Publication Date
SE395221B true SE395221B (sv) 1977-08-08

Family

ID=22052511

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7110354A SE395221B (sv) 1970-08-14 1971-08-13 Sett att framstella en homogen fast blandning av fasta utgangskomponenter

Country Status (9)

Country Link
US (1) US3721725A (de)
JP (1) JPS5339484B1 (de)
CH (1) CH573767A5 (de)
DE (1) DE2140747C3 (de)
FR (1) FR2104349A5 (de)
GB (1) GB1316522A (de)
IT (1) IT995018B (de)
NL (1) NL7111106A (de)
SE (1) SE395221B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154871A (en) * 1975-09-12 1979-05-15 Minnesota Mining And Manufacturing Company Electrostatic coating method utilizing mixture of rough and spheroidized resin particles
US4211015A (en) * 1978-01-18 1980-07-08 Baxter Travenol Laboratories, Inc. Method and apparatus for making novel particulate compositions
DE2804138C3 (de) * 1978-01-31 1980-11-20 Ferrero Ohg, 3570 Stadtallendorf Zahnschonende, wasserarme, zuckerhaltige Lebensmittel und zahnschonende, wasserarme, pharmazeutische Zubereitungen
DE3045488A1 (de) * 1980-12-03 1982-07-01 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von stabilisierten kallikreinhaltigen tabletten
JPS57134498A (en) * 1981-02-12 1982-08-19 Hayashibara Biochem Lab Inc Anhydrous crystalline maltitol and its preparation and use
ATE14047T1 (de) * 1981-12-11 1985-07-15 Wyeth John & Brother Ltd Verfahren und vorrichtung zum gefrieren einer fluessigkeit.
FR2539626B2 (fr) * 1983-01-25 1985-06-21 Lafon Labor Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede
GB8505062D0 (en) * 1985-02-27 1985-03-27 Unilever Plc Processing granulated solids
DE3525648A1 (de) * 1985-07-18 1987-01-29 Bokel Heinz Hermann Dr 1-oxa-2-oxo-2-r-3-aza-5-z-cyclopentanderivate
EP0227441B1 (de) * 1985-12-20 1991-05-15 E.I. Du Pont De Nemours And Company Herstellung von Tabletten aus mikrobiologischen Substanzen
US5009994A (en) * 1986-03-24 1991-04-23 Em Diagnostic Systems, Inc. Particles containing mannitol suitable for tabletting into diagnostic reagents
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
SE8703675L (sv) * 1987-09-23 1989-03-24 Life Science International Ab Luminometrisk analys paa cellulaert atp
US4848094A (en) * 1988-04-29 1989-07-18 Union Carbide Corporation Droplet freezing method and apparatus
ATE99545T1 (de) * 1989-03-29 1994-01-15 Takeda Chemical Industries Ltd Zusammensetzung mit einer verbindung der vitamin b-gruppe und ihre herstellung.
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
DE4007164A1 (de) * 1990-03-07 1991-09-12 Linde Ag Verfahren und vorrichtung zum gefrieren von fliessfaehiger materie
US8067149B2 (en) 1990-09-12 2011-11-29 Lifecell Corporation Acellular dermal matrix and method of use thereof for grafting
US5336616A (en) * 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
AU650045B2 (en) * 1990-09-12 1994-06-09 Lifecell Corporation Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions
US5192312A (en) * 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
US5413732A (en) * 1991-08-19 1995-05-09 Abaxis, Inc. Reagent compositions for analytical testing
US5776563A (en) * 1991-08-19 1998-07-07 Abaxis, Inc. Dried chemical compositions
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
DK71993D0 (da) * 1993-06-18 1993-06-18 Novo Nordisk As Enzym
WO1995024873A1 (en) * 1994-03-14 1995-09-21 Cryolife, Inc. Treated tissue for implantation and preparation methods
FR2720645B1 (fr) * 1994-06-03 1996-08-02 Oreal Procédé d'obtention d'une matière première sous forme de granulés, matière première sous forme de granulés et son utilisation dans le domaine cosmétique, capillaire, vétérinaire ou pharmaceutique.
US5565318A (en) * 1994-09-02 1996-10-15 Pharmacia Biotech, Inc. Room temperature stable reagent semi-spheres
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
US5958455A (en) * 1996-02-09 1999-09-28 Quadrant Holdings Cambridge Ltd Oral solid dosage forms, methods of making same and compositions thereof
GB2329124B (en) * 1997-09-12 2002-05-08 Hiran Asoka Malinga Ratwatte Method of forming dose units of active agents
DK1077609T3 (da) * 1998-05-13 2008-10-20 Novozymes Inc Metode til anvendelse af cellobiose dehydrogenase i bagning
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
CA2346345C (en) * 1998-10-15 2005-04-26 The Procter & Gamble Company Method for making a nanoporous granular material and a detergent composition
US6277407B1 (en) * 1998-11-10 2001-08-21 Frederick S. Marius Apparatus and method for tablet fabrication
JP4536304B2 (ja) * 1999-07-14 2010-09-01 スペクトラル ダイアグノスティックス インコーポレイテッド 診断試験用球体の調製
DE19933289A1 (de) * 1999-07-15 2001-01-18 Basf Ag Verfahren zur Herstellung eines Granulats aus einer Schmelze
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
US20040022861A1 (en) * 2001-01-30 2004-02-05 Williams Robert O. Process for production of nanoparticles and microparticles by spray freezing into liquid
JP2004517699A (ja) * 2001-01-30 2004-06-17 ボード オブ リージェンツ ユニバーシティ オブ テキサス システム 液体中への噴霧凍結によるナノ粒子およびミクロ粒子の製造方法
EP2022557A1 (de) * 2007-08-06 2009-02-11 Laboratories Development LLC Verfahren zur Herstellung von granuliertem gefrorenem Pulver
EP2163239A1 (de) 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
RU2448309C2 (ru) * 2010-05-17 2012-04-20 Государственное образовательное учреждение высшего профессионального образования Томский государственный университет систем управления и радиоэлектроники (ТУСУР) Способ приготовления биологически активного льда
US10724017B1 (en) 2017-12-06 2020-07-28 Cepheid Inhibition of DNA polymerases by uracil-DNA glycosylase-cleavable oligonucleotide ligands
US10724083B1 (en) 2017-12-06 2020-07-28 Cepheid Inhibition of nucleic acid polymerases by endonuclease V-cleavable oligonucleotide ligands
US10689629B1 (en) 2017-12-06 2020-06-23 Cepheid Inhibition of nucleic acid polymerases by endonuclease V-cleavable circular oligonucleotide ligands

Also Published As

Publication number Publication date
FR2104349A5 (de) 1972-04-14
CH573767A5 (de) 1976-03-31
DE2140747B2 (de) 1979-08-23
IT995018B (it) 1975-11-10
US3721725A (en) 1973-03-20
JPS5339484B1 (de) 1978-10-21
NL7111106A (de) 1972-02-16
GB1316522A (en) 1973-05-09
DE2140747C3 (de) 1980-04-24
DE2140747A1 (de) 1972-02-17

Similar Documents

Publication Publication Date Title
SE395221B (sv) Sett att framstella en homogen fast blandning av fasta utgangskomponenter
SE389903B (sv) Sett att bortskaffa avfall
SE422413B (sv) Sett att adiabatiskt separera gasblandningar
SE392391B (sv) Sett att framstella en kottanalog av en degliknande proteinblandning
SE393383B (sv) Sett att framstella adenosinderivat
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE412586B (sv) Sett att framstella isoflavonderivat
SE417316B (sv) Sett att framstella piperazinyl-kinoxalin-foreningar
SE373582B (sv) Sett att separera blandade diastereoisomerer av zearalanol
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE7608643L (sv) Sett att framstella segmentpolymerisat
SE382215B (sv) Sett att framstella kromanderivat
SE391181B (sv) Sett att framstella kinazolinderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE389116B (sv) Sett att syntetisera pteridiner
SE399270B (sv) Sett att framstella spirolaktonsteroider
SE431745B (sv) Sett att framstella en laddning av drivkrut
SE397679B (sv) Sett att framstella kinazolinonderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE428471B (sv) Sett att framstella imidazolderivat
SE417830B (sv) Sett att framstella vissa sulfonylmetylsubstituerade bicykloalkanoner
SE405860B (sv) Sett att framstella rent kristallint penicillinacylas
SE390301B (sv) Sett att framstella butyrfenonederivat
SE384967B (sv) Sett att framstella karieshemmande sackaros